Showing results (31-40 of 73) with videos related to

Sort By:
Pageof 8
Frontiers in Oncology|February 15, 2021
Case Report: B Lymphocyte Disorders Under COVID-19 Inflammatory PressureGloria Taliani, Elena Follini, Lorenzo Guglielmetti, et al.
World Journal of Surgical Oncology|October 21, 2010
Ultrasound-guided central venous catheterization in cancer patients improves the success rate of cannulation and reduces mechanical complications: a prospective observational study of 1,978 consecutive catheterizationsLuigi Cavanna, Giuseppe Civardi, Daniele Vallisa, et al.
Leukemia|January 22, 2026
Immunomodulatory effect of dasatinib plus blinatumomab versus ponatinib plus blinatumomab in newly diagnosed Ph+ acute lymphoblastic leukemiaMichela Ansuinelli, Nadia Peragine, Maria Stefania De Propris, et al.
Clinical Lymphoma & Myeloma|May 2, 2009
Response-guided ABVD chemotherapy plus involved-field radiation therapy for intermediate-stage Hodgkin lymphoma in the pre-positron emission tomography era: a Gruppo Italiano Studio Linfomi (GISL) prospective trialEmilio Iannitto, Viviana Minardi, Paolo G Gobbi, et al.
Recenti Progressi in Medicina|December 20, 2021
[Territorial-based management of patients with cancer on active treatment following the Piacenza (north Italy) Model. Results of 4 consecutive years.]Luigi Cavanna, Chiara Citterio, Camilla Di Nunzio, et al.
Experimental Hematology|November 12, 2013
Endothelium-mediated survival of leukemic cells and angiogenesis-related factors are affected by lenalidomide treatment in chronic lymphocytic leukemiaRossana Maffei, Stefania Fiorcari, Jenny Bulgarelli, et al.
Haematologica|January 18, 2015
The genotype of MLH1 identifies a subgroup of follicular lymphoma patients who do not benefit from doxorubicin: FIL-FOLL studyDavide Rossi, Alessio Bruscaggin, Piera La Cava, et al.
Leukemia & Lymphoma|December 16, 2015
Safety and efficacy of rituximab plus bendamustine in relapsed or refractory diffuse large B-cell lymphoma patients: an Italian retrospective multicenter studyAnnalisa Arcari, Annalisa Chiappella, Michele Spina, et al.
Hematological Oncology|September 29, 2023
Patients' preferences for chronic lymphocytic leukemia treatment: The CHOICE studyPaolo Sportoletti, Luca Laurenti, Annalisa Chiarenza, et al.
Hematological Oncology|October 3, 2012
Risk factors for impaired gonadal function in female Hodgkin lymphoma survivors: final analysis of a retrospective multicenter joint study from Italian and Brazilian InstitutionsSimona Falorio, Irene Biasoli, Stefano Luminari, et al.
Pageof 8